An effective stent for most
- PMID: 37080685
- PMCID: PMC12245411
- DOI: 10.1016/j.jvsv.2023.01.002
An effective stent for most
Comment on
-
Twelve-month end point results from the evaluation of the Zilver Vena venous stent in the treatment of symptomatic iliofemoral venous outflow obstruction (VIVO clinical study).J Vasc Surg Venous Lymphat Disord. 2023 May;11(3):532-541.e4. doi: 10.1016/j.jvsv.2022.12.066. Epub 2023 Jan 13. J Vasc Surg Venous Lymphat Disord. 2023. PMID: 36646383 Free PMC article. Clinical Trial.
References
-
- Hofmann L.R., Gagne P., Brown J.A., Saunders A., Comerota A., on behalf of the VIVO Study Investigators Twelve-month end point results from the evaluation of the Zilver Vena venous stent in the treatment of symptomatic iliofemoral venous outflow obstruction (VIVO clinical study) J Vasc Surg Venous Lymphat Disord. 2023;11:532–541. - PubMed
-
- Razavi M.K., Black S., Gagne P., Chiacchierini R., Nicolini P., Marston W., et al. Pivotal study of endovenous stent placement for symptomatic iliofemoral venous obstruction. Circ Cardiovasc Interv. 2019;12:e008268. - PubMed
-
- Murphy E., Gibson K., Sapoval M., Dexter D.J., Kolluri R., Razavi M., et al. Pivotal study evaluating the safety and effectiveness of the Abre Venous Self-Expanding Stent System in patients with symptomatic iliofemoral venous outflow obstruction. Circ Cardiovasc Interv. 2022;1:e010960. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
